Physician profile
Tyler Walker
NPI 1003427188
$1,789.55
in general payments reported to CMS, 2019-2025
21 companies · $514 in 2025
The $514 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.38 · 2023: $116 · 2024: $1,123 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $329.52 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Idorsia Pharmaceuticals US INC | $223.72 | 2024 | Quviviq |
| Abbvie INC. | $164.78 | 2023-2024 | |
| Lilly USA, LLC | $126.81 | 2024-2025 | Zepbound, Jardiance |
| Kyowa Kirin, INC. | $120.64 | 2024 | |
| Exact Sciences Corporation | $109.34 | 2024-2025 | Cologuard Collection Kit |
| Organon LLC | $101.80 | 2025 | Vtama |
| Novo Nordisk INC | $101.42 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Alk-Abello, INC | $98.99 | 2024 | |
| Pharming Healthcare, INC. | $97.29 | 2023 | Joenja |
| Azurity Pharmaceuticals, INC. | $87.13 | 2024 | Horizant |
| Lundbeck LLC | $53.74 | 2025 | Rexulti |
| Bolton Medical INC | $36.38 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.54 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.70 | 2025 | Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.42 | 2025 | Xifaxan |
| Tris Pharma INC | $18.08 | 2024 | Dyanavel Xr |
| Acella Pharmaceuticals, LLC | $17.46 | 2024 | NP Thyroid 60 |
| Paratek Pharmaceuticals, INC. | $15.16 | 2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $13.98 | 2025 | Zoryve |
| Currax Pharmaceuticals LLC | $13.65 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.